semaglutide weight loss muncie Minnesota doctor says FDA weight-loss drug cutoff is 'devastating' for patients Here's a quick breakdown of

Published in Phytomedicine, 2026

This dual-action mechanism is why tirzepatide is often referred to in medical literature as a twincretin. The development of a molecule that could successfully activate both pathways without significant safety concerns took years of laboratory research before it ever reached human trials

Furthermore, it has been found to be well-tolerated, with a low risk of adverse effects

What the Research Found The research, published in the Annals of Internal Medicine , examined whether people with type 2 diabetes taking GLP-1 receptor agonists such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) face a higher risk of ischaemic optic neuropathy

The no-DAC variants short half-life ensures GH is released in discrete bursts that respect somatostatins inhibitory feedback an important distinction in research models where physiological GH axis dynamics are the experimental focus

Studies show it was the first GH secretagogue this selective it raises GH without raising cortisol, prolactin, or ACTH stress hormones